The 13th call for proposals of the Innovative Medicines Initiatives 2 (IMI2) will open with a topic on “Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches”.
The Vascular Biology laboratory at the Technical University in Munich, led by new Cardiolinc member Lars Maegdefessel, is looking for a Postdoctoral researcher with experience in molecular cell biology/physiology.
Cardiolinc partner Biogazelle and Bio-Rad offer a webinar on droplet digital PCR. You will learn:
- Digital PCR technology
- Applications and use cases, focusing on the analysis of liquid biopsies
- Framework for good experimental practice, including guidelines for assay design, data analysis, and proper reporting standards
The Cardiolinc Annual Meeting (held in Barcelona) had a friendly and supportive atmosphere around afternoon snacks, offered by our sponsor Biogazelle.
A postdoctoral position is available until February 2020 for a highly motivated scientist study the role of non-coding RNA in cardiovascular disease at the University of Edinburgh.
Find out more about the upcoming Cardiolinc Meeting 2017! All Cardiolinc members and partners are invited to join us in Barcelona on August 27.
The introductory article of the European Journal of Heart Failure June edition, written by Editor-in-Chief and Cardiolinc member Prof. Marco Metra, highlights biomarkers for medical treatment and features the review on circular RNAs in heart failure written in collaboration by Cardiolinc members.